Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seungtaek Lim

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Therapeutic Advances in Medical Oncology|December 20, 2021
Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)Sung-Bae Kim, Jae Hong Seo, Jin-Hee Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2013
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancerSeungtaek Lim, Byoung Chul Cho, Ji Ye Jung, et al.
Cancer Medicine|July 30, 2019
Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analysis: KCSG GU 17-03Woo Kyun Bae, Hyo Jin Lee, Se Hoon Park, et al.
Translational Lung Cancer Research|April 15, 2026
Molecular and clinical disparity of <i>EGFR</i>-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and <i>EGFR</i> molecular subtypesDayoung Yoon, Ji Won Lee, Byoung Chul Cho, et al.
Cancer Research and Treatment|March 28, 2022
Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09)Jieun Lee, Keun Seok Lee, Sung Hoon Sim, et al.
Cancer Research and Treatment|May 21, 2021
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic AlterationsYoon Ji Choi, Jung Yoon Choi, Ju Won Kim, et al.
BMC Cancer|August 10, 2025
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)Jieun Lee, Hee Kyung Ahn, Kyung-Hun Lee, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Therapeutic Advances in Medical Oncology|December 20, 2021
Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)Sung-Bae Kim, Jae Hong Seo, Jin-Hee Ahn, et al.
Lung Cancer (Amsterdam, Netherlands)|March 21, 2013
Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancerSeungtaek Lim, Byoung Chul Cho, Ji Ye Jung, et al.
Cancer Medicine|July 30, 2019
Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node-positive bladder cancer: A retrospective analysis: KCSG GU 17-03Woo Kyun Bae, Hyo Jin Lee, Se Hoon Park, et al.
Translational Lung Cancer Research|April 15, 2026
Molecular and clinical disparity of <i>EGFR</i>-mutant non-small cell lung cancer (NSCLC) based on histopathological stage and <i>EGFR</i> molecular subtypesDayoung Yoon, Ji Won Lee, Byoung Chul Cho, et al.
Cancer Research and Treatment|March 28, 2022
Impacts of Subtype on Clinical Feature and Outcome of Male Breast Cancer: Multicenter Study in Korea (KCSG BR16-09)Jieun Lee, Keun Seok Lee, Sung Hoon Sim, et al.
Cancer Research and Treatment|May 21, 2021
Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic AlterationsYoon Ji Choi, Jung Yoon Choi, Ju Won Kim, et al.
BMC Cancer|August 10, 2025
Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)Jieun Lee, Hee Kyung Ahn, Kyung-Hun Lee, et al.
Pageof 3